ChiCTR2100052521 版本V1.1 版本创建时间2022/04/30 20:32:55 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100052521 

最近更新日期:

Date of Last Refreshed on:

2021-10-30 13:00:16 

注册时间:

Date of Registration:

2021-10-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

剖宫产同时获取卵母细胞冷冻保存生育力的研究

Public title:

Study on fertility cryopreservation of oocytes obtained by cesarean section

注册题目简写:

English Acronym:

研究课题的正式科学名称:

妇产科学

Scientific title:

Gynecology

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张英 

研究负责人:

徐丛剑 

Applicant:

Zhang Ying 

Study leader:

Xu congjian 

申请注册联系人电话:

Applicant telephone:

13818218839

研究负责人电话:

Study leader's
telephone:

13651796353

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

13818218839@163.com

研究负责人电子邮件:

Study leader's E-mail:

xucongjian1275@fckyy.org.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市杨浦区沈阳路128号

研究负责人通讯地址:

上海市杨浦区沈阳路128号

Applicant address:

128# shengyang RD

Study leader's address:

128# shengyang RD

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

复旦大学附属妇产科医院

Applicant's institution:

OBGYN hospital of fudan university

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021-151

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

复旦大学附属妇产科医院伦理委员会

Name of the ethic committee:

The ethic committee of OBGYN hospital of fudan university

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

鞠丹丹

Contact Name of the ethic committee:

Ju dandan

伦理委员会联系地址:

上海市黄浦区方斜路566号

Contact Address of the ethic committee:

566# Fangxie Road Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

复旦大学附属妇产科医院

Primary sponsor:

OBGYN hospital of fudan university

研究实施负责(组长)单位地址:

上海市沈阳路128号

Primary sponsor's address:

128# shengyang RD Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦大学附属妇产科医院

具体地址:

杨浦区沈阳路128号

Institution
hospital:

Obstetrics and Gynecology Hospital of Fudan University

Address:

128 Shenyang Road, Yangpu District

经费或物资来源:

复旦大学附属妇产科医院

Source(s) of funding:

OBGYN hospital of fudan university

研究疾病:

无  

Target disease:

NO

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

病例研究 

Study design:

Case study 

研究目的:

探索剖宫产同时穿刺卵巢表面卵泡,获取卵母细胞进行体外培养后进行玻璃化冻存保存生育力的安全性和有效性。  

Objectives of Study:

To explore the safety and effectiveness of vitrification cryopreservation for fertility preservation by puncturing ovarian follicles at the same time during cesarean section.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1) 妊娠女性
2) 强烈要求保存生育力
3) 年龄≤40岁
4) 剖宫产手术分娩
5) 受试者自愿加入本研究,签署知情同意书,依从性好,配合随访

Inclusion criteria

1) pregnancy women2) urged preserve fertility 3) pregnancy women age 40 years old or less 4) surgery cesarean section delivery 5) willing to join in this study, subjects signed informed consent, good adherence, cooperate with the follow-up

排除标准:

1) 患有传染性疾病者(HIV 梅毒 肝炎等)
2) 孕前已发现卵巢功能减退(AMH <1ng/ml和/或窦卵泡数<5个)

Exclusion criteria:

1) people with infectious diseases (HIV syphilis, hepatitis, etc.) 2) pregnant has found that decreased ovarian function (AMH < 1 ng/ml and/or sinus follicle number < 5)

研究实施时间:

Study execute time:

From 2021-10-25 00:00:00 To 2024-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-11-01 00:00:00 To 2024-09-30 00:00:00

干预措施:

Interventions:

组别:

卵母细胞冻存组

样本量:

20

Group:

oocyte cryopreservation group

Sample size:

干预措施:

干预措施代码:

Intervention:

Nil

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦大学附属妇产科医院 

单位级别:

三甲 

Institution
hospital:

Obstetrics and Gynecology Hospital of Fudan University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

内分泌

指标类型:

主要指标

Outcome:

endocrione

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

卵母细胞

组织:

Sample Name:

oocyte

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 40 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

不随机

Randomization Procedure (please state who generates the random number sequence and by what method):

no

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

完成后6月内

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

within 6 months after the trial complete

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-10-30 13:00:12